Connection

DAVID POPLACK to Drug Resistance

This is a "connection" page, showing publications DAVID POPLACK has written about Drug Resistance.
Connection Strength

0.083
  1. Mechanism of resistance to cyclopentenyl cytosine (CPE-C) in Molt-4 lymphoblasts. Biochem Pharmacol. 1993 Apr 06; 45(7):1493-501.
    View in: PubMed
    Score: 0.025
  2. The child with recurrent solid tumor. Pediatr Clin North Am. 1991 Apr; 38(2):489-504.
    View in: PubMed
    Score: 0.022
  3. Expression of a multidrug-resistance gene in human tumors and tissues. Proc Natl Acad Sci U S A. 1987 Jan; 84(1):265-9.
    View in: PubMed
    Score: 0.016
  4. Pharmacology and drug resistance in childhood lymphoblastic leukemia. Hematol Oncol Clin North Am. 1990 Oct; 4(5):871-94.
    View in: PubMed
    Score: 0.005
  5. Expression of the mdr-1/P-170 gene in patients with acute lymphoblastic leukemia. Blood. 1989 Sep; 74(4):1388-95.
    View in: PubMed
    Score: 0.005
  6. Expression of anionic glutathione-S-transferase and P-glycoprotein genes in human tissues and tumors. Cancer Res. 1989 Mar 15; 49(6):1422-8.
    View in: PubMed
    Score: 0.005
  7. Mechanism of acquired resistance to methotrexate in P388 murine leukemia cells and in their doxorubicin-resistant subline. Isr J Med Sci. 1988 Sep-Oct; 24(9-10):477-82.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.